Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activation markers of coagulation.

K A Bauer1

  • 1Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02132, USA.

Bailliere'S Best Practice & Research. Clinical Haematology
|June 17, 2000
PubMed
Summary

New biochemical markers can detect early signs of hypercoagulability, a state of increased blood clot risk. However, their clinical utility in managing patients or predicting thrombosis requires further investigation through prospective studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancements in Laser-Direct-Drive Nuclear Performance with Target Radius.

Physical review letters·2026
Same author

Applications of a Rayleigh-Taylor model to direct-drive laser fusion.

Physical review. E·2024
Same author

Persistent Hot-Spot Mix in Cryogenic Direct-Drive Fusion Experiments.

Physical review letters·2024
Same author

Optical characterization of the on-target OMEGA focal spot at high energy using the full-beam in-tank diagnostic.

Applied optics·2020
Same author

Tripled yield in direct-drive laser fusion through statistical modelling.

Nature·2019
Same author

Power balancing the multibeam OMEGA laser.

Applied optics·2018

Area of Science:

  • Biochemistry
  • Hematology
  • Clinical Chemistry

Background:

  • Advances in understanding the biochemistry of hemostasis.
  • Development of sensitive assays for coagulation system activation markers.

Purpose of the Study:

  • To review the utility of biochemical markers in assessing hypercoagulable states.
  • To evaluate the potential of these markers in clinical management and thrombosis prediction.

Main Methods:

  • Measurement of peptides, enzyme-inhibitor complexes, and enzymes released during coagulation activation.
  • Analysis of studies using these markers in normal and pathological conditions.

Main Results:

  • Biochemical markers can indicate a hypercoagulable state before overt thrombosis.
  • Current markers lack proven utility in individual patient management.

Conclusions:

  • Prospective studies are needed to validate assay techniques for identifying at-risk patients.
  • Further research is required to determine the role of these markers in monitoring antithrombotic therapy.

Related Experiment Videos